UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation

The European respiratory journal, 2011-03, Vol.37 (3), p.624-631

2011

Volltextzugriff (PDF)

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR -mutant non-small cell lung cancer: A new era begins

Cancer treatment reviews, 2014-02, Vol.40 (1), p.93-101

2014

Volltextzugriff (PDF)

Malignant pleural mesothelioma: New hope in the horizon with novel therapeutic strategies

Cancer treatment reviews, 2015-01, Vol.41 (1), p.27-34

2015

Volltextzugriff (PDF)

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

Annals of oncology, 2006-11, Vol.17 (11), p.1698-1704

2006

Volltextzugriff (PDF)

Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer

Annals of oncology, 2004-08, Vol.15 (8), p.1194-1203

2004

Volltextzugriff (PDF)

Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group

Lung cancer (Amsterdam, Netherlands), 2020-09, Vol.147, p.83-90

2020

Volltextzugriff (PDF)

Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma

Annals of oncology, 2005-06, Vol.16 (6), p.923-927

2005

Volltextzugriff (PDF)

Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus

Clinical & translational oncology, 2020-05, Vol.22 (5), p.759-771

2020

Volltextzugriff (PDF)

Beyond EGFR TKI in EGFR -mutant Non-Small Cell Lung Cancer patients: Main challenges still to be overcome

Cancer treatment reviews, 2014-07, Vol.40 (6), p.723-729

2014

Volltextzugriff (PDF)

miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers

Clinical & translational oncology, 2016-02, Vol.18 (2), p.153-159

2016

Volltextzugriff (PDF)

Long‐term abiraterone withdrawal syndrome

Journal of clinical pharmacy and therapeutics, 2018-10, Vol.43 (5), p.714-716

2018

Volltextzugriff (PDF)

GECP 1605/NIVEX TRIAL nivolumab in the real world: The SPANISH expanded access program experience in pretreated advanced NSCLC

Annals of oncology, 2018-10, Vol.29, p.viii531-viii531

2018

Volltextzugriff (PDF)

Thyroid cancer: SEOM clinical guidelines

Clinical & translational oncology, 2014-12, Vol.16 (12), p.1035-1042

2014

Volltextzugriff (PDF)

A consensus statement on the gender perspective in lung cancer

Clinical & translational oncology, 2017-05, Vol.19 (5), p.527-535

2017

Volltextzugriff (PDF)

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Annals of oncology, 2002-10, Vol.13 (10), p.1539-1549

2002

Volltextzugriff (PDF)

Medical oncology future plan of the Spanish Society of Medical Oncology: challenges and future needs of the Spanish oncologists

Clinical & translational oncology, 2017-04, Vol.19 (4), p.508-518

2017

Volltextzugriff (PDF)

Lung cancer in women: an overview with special focus on Spanish women

Clinical & translational oncology, 2014-06, Vol.16 (6), p.517-528

2014

Volltextzugriff (PDF)

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database

Clinical & translational oncology, 2017-12, Vol.19 (12), p.1537-1542

2017

Volltextzugriff (PDF)

Erratum to: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions

Clinical & translational oncology, 2017-04, Vol.19 (4), p.525-525

2017

Volltextzugriff (PDF)

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

Journal of clinical oncology, 1994-02, Vol.12 (2), p.360-367

1994

Volltextzugriff (PDF)

SEOM clinical guidelines for the treatment of small-cell lung cancer 2013

Clinical & translational oncology, 2013-12, Vol.15 (12), p.985-990

2013

Volltextzugriff (PDF)

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.143-150

2003

Volltextzugriff (PDF)

Altered Patterns of MDM2 and TP53 Expression in Human Bladder Cancer

JNCI : Journal of the National Cancer Institute, 1994-09, Vol.86 (17), p.1325-1330

1994

Volltextzugriff (PDF)

Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study

British journal of cancer, 2007-11, Vol.97 (9), p.1206-1210

2007

Volltextzugriff (PDF)

Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms

Clinical cancer research, 1995-05, Vol.1 (5), p.545-550

1995

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(80)
Science & Technology
(77)
Life Sciences & Biomedicine
(72)
Female
(54)
Male
(50)
Middle Aged
(47)
Adult
(44)
Oncology
(44)
Aged
(36)
Biological And Medical Sciences
(36)
Medical Sciences
(36)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(25)
Antineoplastic Agents
(21)
Chemotherapy
(21)
Pharmacology. Drug Treatments
(21)
Cisplatin - Administration & Dosage
(20)
Lung Neoplasms - Drug Therapy
(17)
Treatment Outcome
(17)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(14)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR -mutant non-small cell lung cancer: A new era begins

Malignant pleural mesothelioma: New hope in the horizon with novel therapeutic strategies

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer

Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group

Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma

Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus

Beyond EGFR TKI in EGFR -mutant Non-Small Cell Lung Cancer patients: Main challenges still to be overcome

miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers

Long‐term abiraterone withdrawal syndrome

GECP 1605/NIVEX TRIAL nivolumab in the real world: The SPANISH expanded access program experience in pretreated advanced NSCLC

Thyroid cancer: SEOM clinical guidelines

A consensus statement on the gender perspective in lung cancer

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Medical oncology future plan of the Spanish Society of Medical Oncology: challenges and future needs of the Spanish oncologists

Lung cancer in women: an overview with special focus on Spanish women

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database

Erratum to: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

SEOM clinical guidelines for the treatment of small-cell lung cancer 2013

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Altered Patterns of MDM2 and TP53 Expression in Human Bladder Cancer

Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study

Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms

Suchergebnisse filtern